Emtricitabine-d2,15N

CAS: 143491-57-0

Ref. 3D-NE153331

Produktinformation

• Name: Emtricitabine-d2,15N
• Synonyme: (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, (-)-2'-Deoxy-5-fluoro-3'-thiacytidine, (-)-2′,3′-Dideoxy-5-fluoro-3′-thiacytidine, (-)-Beta-2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine, (-)-Ftc, 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv., 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-5-oxathiolanyl]-, 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-, 4-Amino-5-Fluoro-1-(2-(Hydroxymethyl)-1,3-Oxathiolan-5-Yl)-(2R-Cis)-2(1H)-Pyrimidinone, 4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one, 524W91, Bw 1592, Bw 524W91, Coviracil, Emitricibatine, Emitricitabine, Emtricitabin, Emtritabine, Emtriva, Fumitremorgin C, Sm-Q

Beschreibung

Emtricitabine-d2,15N is a labelled version of emtricitabine. It is a nucleoside reverse transcriptase inhibitor that inhibits the HIV-1 virus by blocking the activity of the enzyme needed to convert RNA into DNA. This drug also offers long-term efficacy and can be used in combination with other antiretroviral agents including tenofovir alafenamide hemifumarate (TAF) and tenofovir disoproxil fumarate (TDF). The addition of TAF or TDF to emtricitabine-d2,15N provides an active antiretroviral therapy for HIV/AIDS patients. Emtricitabine-d2,15N has shown to reduce viral load significantly in people taking it as part of their treatment regimen.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 257.3 g/mol
• Formel: C₈D₁₀FN₃O₃S
• Reinheit: Min. 95%